Zusammenfassung
Das Wiederauftreten depressiver und manischer Episoden zu verhindern, ist nicht nur wegen der sozialen und ökonomischen, sondern auch wegen der familiären und insbesondere individuellen Konsequenzen für den einzelnen Patienten ein vordringliches Ziel.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahrens B (1995a) Suizidprävention and Langzeittherapie bei affektiven Störungen. In: Wolfersdorf M, Kaschka W P (Hrsg) Suizidalität - die biologische Dimension. Springer, Berlin Heidelberg New York, 175–191
Ahrens B (1995b) Lithium treatment and suicide prevention in affective disorders. European Neuropsychopharmacology 5: 301
Ahrens B, Müller-Oerlinghausen B, Schou M et al. (1995) Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium-prophylaxis. Journal of Affective Disorders 33: 67–75
Ahrens B, Linden M (1996) Is there a suicidality syndrome independet of specific major psychiatric disorder? Results of a split half multiple regression analysis. Acta Psychiatr Scand 94: 79–86
Angst J (1986) The course of affective disorders. In: Latest findings on the aetiology and therapy of depression. Psychopathology (suppl 2) 19: 47–52
Asberg M, Nordström P (1988) Biological correlates of suicidal behavior. In: Möller HJ, Schmidtke A, Welz R (eds) Current Issues of Suicidology. Springer, Berlin, pp 221–241
Bauer M (1996) Adjuvante Schilddrüsenhormonbehandlung bei affektiven Psychosen. Psycho 22: 4: 288–290
Bauer M (1994) Refractoriness induced by lithium discontinuation despite adequate serum lithium levels. Am J Psychiatry 151: 1522
Bauer M, Ahrens B (1996) Bipolar Disorder: A practical guide to drug treatment. CNS Drugs 6 (1): 35–52
Berghöfer A, Müller-Oerlinghausen B (1996) No loss of efficacy after discontinuation and reinstitution of long-term lithium treatment? In: Gallicchio V et al. (eds) Lithium: Biochemical and Clinical Advances. (in press)
Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Agression in humans correlates with cerebrospinal fluid amine metabolite. Psychiatr Res 1: 139
Cohen LS, Friedman JM, Jefferson et al.(1994) A reevaluation of risk of in utero exposure to lithium. JAMA; 271: 146–150
Coppen A (1994) Depression as a Lethal Disease: Prevention Strategies. J Clin Psychiatry 55 (4, suppl): 37–45
Coppen A, Abou-Saleh MT, Milln P et al. (1983) Decreasing lithium dosage reduces morbidity and side effects during prophylaxis. J Affective Disord 5: 353–362
Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Affective Disord 23:1–7
Coxhead N, Silverstone T, Cookson J (1992) Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand; 85:114–118
Dilling H, Mombour W, Schmidt M H (Hrsg) (1993) Internationale Klassifikation psychischer Störungen, ICD-10, Kapitel V (F). Klinisch-diagnostische Leitlinien (2. Auflage). Huber, Bern Gsttingen Toronto
Fawcett J (1995) Compliance Definitions and Key Issues. J Clin Psychiatry (1995) 56, Suppl 1
Goodwin F K, Jamison K R (1990) Manic-Depressive Illness. Oxford University Press, New York
Greil W, Ludwig-Mayerhofer W, Czernik A et al. (1994) Lithium-oder Carbamazepinprophylaxe bei affektiven Psychosen? Ergebnisse einer kontrollierten, multizentrischen Studie. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, 113–119
Grof P, Ahrens B, Yamamotova A et al. (1994) Chronobiologische Verlaufsmuster affektiver Erkrankungen. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg). Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, S 67–78
Guze S B, Robins E (1970) Suicide in primary affective disorders. Br J Psychiatry 117: 437–338
Källen AJB (1994) Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8: 203–205
Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983) Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33: 2609
McElroy SL, Keck PE Jr, Pope HG Jr et al. (1989) Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry; 50 (3, Suppl): 23–29
Müller-Oerlinghausen B (1985) Lithium long-term treatment - does it act via serotonin? Pharmacopsychiatry 18: 214–217
Müller-Oerlinghausen B, Ahrens B, Grof E et al. (1992a) The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatr Scand 86: 218–222
Müller-Oerlinghausen B, Müser-Causemann B, Volk J (1992b) Suicides and parasuicides in a high-risk patient group on and off Lithium long-term medication J Affective Disord 25: 261–270
Nilsson A (1994) Lithium und menschliche Aggression. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, S 27–33
Nurnberg H G, Martin G A, Karajgi B M et al. (1994) Response to anticonvulsant substitution among refractory bipolar manic patients. J Clin Psychopharmacol 14: 207–208
Omtzigt JGC, Los FJ, Grobbee DE et al. (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42 (Suppl. 5):119–125
Post R M (1992) The transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149: 999–1010
Post R M, Leverich G S, Altshuler L, Mikalauskas K (1992) Lithium -discontinuation induced refractoriness: preliminary observations. Am J Psychiatry 149; 1727–1729
Post RM, Leverich GS, Pazzaglia PJ et al. (1993) Lithium tolerance and discontinuation as pathways to refractoriness. In: Birch NJ Padgham C, Hughes MS (eds) Lithium in medicine and biology. Carnforth: Mareius Press, pp 71–84
Quitkin FM, Kane J, Rifkin A et al. (1981) Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. Arch Gen Psychiatry 38: 902–907
Schou M (1984) Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70: 594–602
Schou M (1991) Relapse prevention in manic-depressive illness: Important and unimportant factors. Can J Psychiatry 36: 502–506
Schou M (1993) Lithium Treatment of Manic-Depressive Illness: A Practical Guide, 5th ed. S Karger, New York
Schou M (1995) Is there a lithium withdrawal syndrome? An examination of the evidence. Brit J Psychiatry 163: 514–518.
Schumann C, Lenz G (1996) Zur Compliance bei Rezidivprophylaxe von affektiven Störungen. psycho 22, 4: 282–287
Thies-Flechtner K, Seibert W, Walther A et al. (1994) Suizide bei rezidivprophylaktisch behandelten Patienten mit affektiven Psychosen. In: Müller-Oerlinghausen B, Berghöfer A (Hrsg) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Thieme Verlag, Stuttgart New York, S 61–64
Träskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38: 631–636
Valzelli L, Garattini S (1972) Biochemical and behavioural changes induced by isolation in rats. Neuropharmacology 11: 17
Waters C H, Belai Y, Gott P S, et al. (1994) Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 51: 250–253
Whybrow PC (1994) The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder. Acta med Austriaca 21: 47–52
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ahrens, B. (1997). Rezidivprophylaxe bipolarer Störungen: Aktuelle Aspekte. In: Wolfersdorf, M. (eds) Depressionsstationen/Stationäre Depressionsbehandlung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60807-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-60807-0_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62902-3
Online ISBN: 978-3-642-60807-0
eBook Packages: Springer Book Archive